One of the most consistent challenges in running a clinical trial is successfully recruiting a targeted population that also represents the diversity and inclusion in the world. Historically, many studies fail to reach recruitment numbers and even fewer manage to enroll representative populations. By including patient voices early and often, this can change.
The US Food and Drug Administration (FDA) has recently released draft guidance suggesting clinical pipelines submit a diversity and inclusion strategy early in their development. A key to achieving the regulatory, ethical and scientific components of any diversity and inclusion strategy is listening to patient voices. In this webinar, hear from the featured speakers — an industry analyst, an entrepreneur bringing patient voice directly into the trial design and recruitment strategies and a patient advocate who is reshaping the conversation around patient inclusion. Attendees will gain a foundational understanding of broad market trends, clarity on how technology is specifically enabling data-driven insights into study-specific populations and hear about the real world impact on patients.
Join this webinar to hear about the evolving role of patient voice and diversity, insights from advocates and leaders and specific strategies to apply to clinical study or pipeline.
Noah Goodson, PhD, Director, Consulting, THREAD Research
Prior to joining THREAD, Noah helped early-stage biotech and medical device companies design and execute hybrid and fully decentralized research. He is well-versed in the complex needs of these organizations and has spent significant time in guiding business development and scientific communication strategies with investors. As part of THREAD Consulting, Noah applies practical experience in running trials with a decentralized approach to build more efficient and inclusive studies.Message Presenter
Chunky Satija, Vice-President, Everest Group
Chunky Satija is a Vice President at Everest Group leading the Life Sciences and Healthcare research practices and is responsible for its vision and growth. He advises business and technology leaders of life sciences and healthcare enterprises, software vendors, service providers and investors on a wide range of topics: including go-to-market strategy, vendor identification and prioritization and market positioning.
In his previous role, he worked as a Life Sciences R&D Consultant advising leaders of clinical, safety, regulatory, medical affairs, market access and quality functions in top 20 biopharma organizations. He holds a master’s and bachelor’s degree in technology from the Indian Institute of Technology, Delhi.Message Presenter
Fabio Gratton, Cofounder and CEO of inVibe Labs, a Division of THREAD
Fabio Gratton is a digital health entrepreneur. For over two decades he has adapted his early experience as a Hollywood scriptwriter with innate acumen in science and data to redefine how healthcare companies tell patient stories through technology. Of his many Fortune 5000 ventures, inVibe has redefined qualitative market research by enabling brands to supplement their efforts with flexible, scalable and impactful voice-driven insights.Message Presenter
Dima Hendricks, Sickle Cell Health Coach, University of Pittsburgh
Boston native, Dima Hendricks is an advocate and an ambassador for change.
Born with Sickle Cell, a hereditary blood disorder, Dima suffered numerous health complications. But that never held her back. Today she stands on the front lines raising awareness about the dangers of sickle cell disease and encouraging others to make a difference. Through her work at the local sickle cell organization, the American Red Cross, and the NAACP, Dima has helped change the landscape of awareness in the City of Boston. She is now embarking on a new position as a sickle cell health coach at the University of Pittsburgh.
Who Should Attend?
- Clinical Research
- Clinical Project Managers
- Data Management
- Decentralized/Remote/Virtual Trials
- Digital Innovation/Strategy
- Medical Director
- Patient Experience
- Patient Engagement
- Patient Recruitment
- Trial Design
- Therapeutic Head/Lead
What You Will Learn
- Gain a foundational understanding of broad market trends
- Learn how technology is specifically enabling data-driven insights in study-specific populations
- Hear about real world impact on patients
THREAD is a leading provider of a proprietary, decentralized research platform and suite of supporting services used by biopharma, CROs and life science organizations to remotely capture data from participants and sites during, in-between and in lieu of in-clinic visits. THREAD’s platform and supporting services are helping customers to shorten study launch timelines, reduce study budgets with Virtual Visits, and bring studies from the clinic to patients’ homes. THREAD provides key platform features such as eConsent, eCOA/ePRO, sensors, reminders, and telehealth Virtual Visits to support remote data capture, hybrid virtual studies, and fully decentralized studies in key therapeutic areas. In 2019, THREAD was acquired by strategic health care investors Water Street Healthcare Partners and JLL Partners. Visit us at https://www.threadresearch.com/